The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancer

Seminars in Cancer Biology
Boaz NachmiasDina Ben-Yehuda

Abstract

Apoptosis is a crucial biological process that prevents uncontrolled cell proliferation and eliminates harmful cells. Resistance to apoptotic stimuli is a hallmark feature of various cancers. One of the mechanisms through which tumor cells are believed to acquire resistance to apoptosis is by overexpression of inhibitor of apoptosis proteins (IAPs). IAPs are a group of structurally related proteins that were initially identified in baculoviruses. Mammalian IAPs block apoptosis either by binding and inhibiting caspases or through caspase-independent mechanisms. This family of proteins has become increasingly prominent in the field of cancer biology. To date, overexpression of several IAPs has been detected in various cancers. This paper reviews the recent advances in the research of IAPs. The differential expression and the biological significance of each IAP in various cancer types will be discussed. Finally, we review the most recent advances in the research efforts aimed at using IAPs as potential targets for cancer therapy.

Citations

Feb 18, 2014·International Journal of Molecular Sciences·Mahsa MobahatKarl Riabowol
Apr 4, 2014·Medical Oncology·Lamia IbrahimSuzy A Abd El-Hameed
Mar 1, 2006·BMC Cancer·Magali EspinosaJorge Melendez-Zajgla
Aug 17, 2006·Journal of Virology·Gustavo DelhonDaniel L Rock
Oct 28, 2006·BMC Cancer·Abril Arellano-LlamasJorge Melendez-Zajgla
Sep 29, 2007·Molecular Endocrinology·Yan YinLiang Ma
Oct 2, 2009·Molecular Biology of the Cell·Lydia LartigueDonald D Newmeyer
Sep 7, 2013·Cell Death & Disease·T K Oberoi-KhanujaK Rajalingam
Mar 25, 2006·Future Oncology·Zodwa DlaminiThokozile Ledwaba
Mar 1, 2006·International Journal of Peptide Research and Therapeutics·Sushil K SharmaLeigh Zawel
Jan 18, 2011·Cancer Immunology, Immunotherapy : CII·Jianqiang ZhaoLiufang Gu
Apr 17, 2012·Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine·Li WengChang-quan Ling
Mar 7, 2006·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Hiroshi HaradaMasahiro Hiraoka
Feb 13, 2007·Apoptosis : an International Journal on Programmed Cell Death·Boaz NachmiasDina Ben-Yehuda
Jul 5, 2007·Apoptosis : an International Journal on Programmed Cell Death·Sebastian HeikausUwe Ramp
Oct 26, 2005·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Xiaoying LiuZhenghong Yuan
Jun 3, 2010·Clinical & Experimental Metastasis·Michelle M Martínez-MontemayorSuranganie Dharmawardhane
Oct 9, 2007·Journal of Cancer Research and Clinical Oncology·Carsten KempkensteffenSteffen Weikert
Aug 24, 2011·Journal of Cancer Research and Clinical Oncology·Julija HmeljakAndrej Cör
Jan 5, 2005·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Syamal K DattaLuting Xu
Jul 15, 2006·Leukemia & Lymphoma·Hongyang WuHanliang Lin
Jan 27, 2010·Expert Opinion on Therapeutic Patents·John A Flygare, Wayne J Fairbrother
Oct 23, 2009·Expert Opinion on Therapeutic Targets·George I Gorodeski
Dec 1, 2008·Expert Review of Respiratory Medicine·Jeong H YunRubin M Tuder
Sep 26, 2007·Expert Review of Anticancer Therapy·Simone Fulda
Jul 15, 2015·International Journal of Oncology·Masaya MinodaToshihiro Akisue
May 23, 2015·Oncology Reports·Caroline AdamsErnesto Yagüe
Jan 2, 2009·Ultrastructural Pathology·Ben Davidson
Jan 5, 2013·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Xin DongYuzhuo Wang
Nov 28, 2015·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Łukasz WoźniakKrystian Marszałek
Apr 16, 2013·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Cheng-Yun JinYung Hyun Choi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

B cells: Gene Expression

B lymphocytes are white blood cells that play a role in the adaptive immune system by secreting antibodies. Here is the latest research on gene expression in B cells.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis